ImmunologybioRxiv
Genetic Modification to Design a Stable Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain as a COVID-19 Vaccine Candidate
W.-H. Chen, J. Wei, R. T. Kundu…·M. E. Bottazzi
The paper genetically modifies SARS-CoV-2 RBD variants in yeast to identify a more stable and manufacturable vaccine candidate.
DOI 10.1016/j.bbagen.2021.129893